Abstract
Abnormalities in tau modification and tau aggregation are a characteristic histopathological hallmark of Alzheimers disease (AD). However it is less clear, how tau pathology is linked to other factors, e.g. the formation of amyloid plaques, mutations in the presenilin gene, or the ApoE genotype that all have been shown to contribute to the disease. In this article, data reporting taus interactions with other factors that may be relevant for AD and that have been obtained from various types of in vitro experiments, cell culture experiments and animal models are summarized and brought into a mechanistic framework. Evidences for functional links of these interactions to neurodegenerative events characteristic for AD are discussed and weighed.
Keywords: alzheimers disease, tau, microtubule-associated protein, neurofibrillary tangles, paired helical filaments, neurodegeneration, cytoskeleton, tauopathy
Current Alzheimer Research
Title: Functional Interactions of Tau and their Relevance for Alzheimers Disease
Volume: 1 Issue: 4
Author(s): Roland Brandt and Julia Leschik
Affiliation:
Keywords: alzheimers disease, tau, microtubule-associated protein, neurofibrillary tangles, paired helical filaments, neurodegeneration, cytoskeleton, tauopathy
Abstract: Abnormalities in tau modification and tau aggregation are a characteristic histopathological hallmark of Alzheimers disease (AD). However it is less clear, how tau pathology is linked to other factors, e.g. the formation of amyloid plaques, mutations in the presenilin gene, or the ApoE genotype that all have been shown to contribute to the disease. In this article, data reporting taus interactions with other factors that may be relevant for AD and that have been obtained from various types of in vitro experiments, cell culture experiments and animal models are summarized and brought into a mechanistic framework. Evidences for functional links of these interactions to neurodegenerative events characteristic for AD are discussed and weighed.
Export Options
About this article
Cite this article as:
Brandt Roland and Leschik Julia, Functional Interactions of Tau and their Relevance for Alzheimers Disease, Current Alzheimer Research 2004; 1 (4) . https://dx.doi.org/10.2174/1567205043332054
DOI https://dx.doi.org/10.2174/1567205043332054 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biological Importance, Therapeutic Benefit and Analytical Aspects of Bioactive Flavonoid Pectolinarin in the Nature
Drug Metabolism Letters Therapy in Prion Diseases
Current Topics in Medicinal Chemistry Is alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
Current Alzheimer Research Harnessing Impaired Energy Metabolism in Cancer Cell: Small Molecule- Mediated Ways to Regulate Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry The Role of α7 Nicotinic Acetylcholine Receptors and α7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease
Current Pharmaceutical Design Autophagy and Cell Death in Caenorhabditis elegans
Current Pharmaceutical Design CAR T-cell Therapy: A New Era in Cancer Immunotherapy
Current Pharmaceutical Biotechnology HER2 in the Era of Molecular Medicine: A Review
Current Cancer Therapy Reviews Cholesterol in Alzheimers Disease: Unresolved Questions
Current Alzheimer Research Human Papillomavirus E7 Oncoprotein Promotes Proliferation and Migration through the Transcription Factor E2F1 in Cervical Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry L-carnitine: Searching for New Therapeutic Strategy for Sepsis Management
Current Medicinal Chemistry Targeting mTOR: Evaluating the Therapeutic Potential of Resveratrol for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Glycosphingolipid Structure and Function in Membranes
Current Organic Chemistry Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design A Role for Calcineurin in Alzheimers Disease
Current Neuropharmacology Astrocytes: Adhesion Molecules and Immunomodulation
Current Drug Targets Exploring the Mitochondrial Apoptotic Cell Death Landscape and Associated Components Serving as Molecular Targets, Primarily for Synthetic and Natural Drugs Targeting Oncology Therapeutics
Current Molecular Pharmacology PP2A and Alzheimer Disease
Current Alzheimer Research Inhibition of Brain Ischemia-Caused Notch Activation in Microglia May Contribute to Isoflurane Postconditioning-Induced Neuroprotection in Male Rats
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic : Targeting Focal Ahhesion Kinase in Cancer-Part I (Guest Editor: Vita M. Golubovskaya)]
Anti-Cancer Agents in Medicinal Chemistry